Tyra Biosciences Inc (TYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,304 | -25,152 | -11,880 | -55,325 | -42,430 |
| Depreciation Amortization | 255 | 172 | 83 | 296 | 214 |
| Other Working Capital | 103 | 556 | -483 | -5,847 | -3,771 |
| Other Operating Activity | 9,339 | 4,962 | 2,433 | 10,591 | 7,682 |
| Operating Cash Flow | $-36,607 | $-19,462 | $-9,847 | $-50,285 | $-38,305 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -167 | -84 | -41 | -559 | -538 |
| Investing Cash Flow | $-167 | $-84 | $-41 | $-559 | $-538 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,213 | 746 | 376 | 632 | 629 |
| Financing Cash Flow | $1,213 | $746 | $376 | $632 | $629 |
| Beginning Cash Position | 252,213 | 252,213 | 252,213 | 302,425 | 302,425 |
| End Cash Position | 216,652 | 233,413 | 242,701 | 252,213 | 264,211 |
| Net Cash Flow | $-35,561 | $-18,800 | $-9,512 | $-50,212 | $-38,214 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,607 | -19,462 | -9,847 | -50,285 | -38,305 |
| Capital Expenditure | -167 | -84 | -41 | -559 | -538 |
| Free Cash Flow | -36,774 | -19,546 | -9,888 | -50,844 | -38,843 |